Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.
D000818:Animals; D001491:Basophils; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005260:Female; D007263:Infusions, Parenteral; D007958:Leukocyte Count; D008244:Lysophosphatidylcholines / Q000494:pharmacology*; D008297:Male; D009503:Neutropenia / Q000139:chemically induced; D009504:Neutrophils; D010972:Platelet Activating Factor; D010974:Platelet Aggregation / Q000187:drug effects; D010976:Platelet Count; D010978:Platelet Factor 4 / Q000378:metabolism; D011817:Rabbits; D013921:Thrombocytopenia / Q000139:chemically induced
D008244:Lysophosphatidylcholines; D010972:Platelet Activating Factor; D010978:Platelet Factor 4